MedTrace Logo

Influence of a PPMTM on Adherence and Clinical Outcomes Among Preterm Infants With Iron Supplementation

NCT04740515 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 236

Last updated 2023-10-13

No results posted yet for this study

Summary

This is a randomised trial on the efficacy of a Pharmacist-led Patient-Centered Medication Therapy Management on clinical outcomes among preterm infants born before 32 weeks gestation with iron supplementation. The purpose of this study is to evaluate clinical outcome in the PPMTM program compared with usual care in an integrated health care system.

Conditions

  • Preterm Infants
  • Clinical Outcome
  • Pharmaceutical Care

Interventions

OTHER

pharmacists involved PPMTM

This was an open labelled randomised study. Preterm Infants With iron supplementation were recruited and arbitrarily divided into the intervention group (usual care plus PPMTM) and the non-intervention group (usual care only). Those enrolled in the research were scheduled for follow-up for eight consecutive visits. Improvements in lab results and direct costs were compared longitudinally (pre and post analysis) between the groups.

Sponsors & Collaborators

  • Shaoxing Maternity and Child Health Care Hospital

    lead OTHER

Principal Investigators

  • Renjie Xu, PhD · Shaoxing Maternity and Child Health Care Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
26 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2022-02-21
Completion
2023-08-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04740515 on ClinicalTrials.gov